Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease

Comparative Study

T Sunderland et al. Lancet. 1989.

. 1989 Sep 2;2(8662):570.

doi: 10.1016/s0140-6736(89)90700-9.

No abstract available

Comment in

Dehydroepiandrosterone sulphate in Alzheimer disease.
Späth-Schwalbe E, Dodt C, Dittmann J, Schüttler R, Fehm HL. Späth-Schwalbe E, et al. Lancet. 1990 Jun 9;335(8702):1412. doi: 10.1016/0140-6736(90)91298-o. Lancet. 1990. PMID: 1971699 No abstract available.
Dehydroepiandrosterone sulphate in Alzheimer's disease.
[No authors listed] [No authors listed] Lancet. 1990 Aug 18;336(8712):449-50. Lancet. 1990. PMID: 1974985 No abstract available.
Dehydroepiandrosterone and Alzheimer's disease.
Mohan PF. Mohan PF. Lancet. 1989 Oct 28;2(8670):1048-9. doi: 10.1016/s0140-6736(89)91069-6. Lancet. 1989. PMID: 2572787 No abstract available.
Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease.
Svec F, Lopez A. Svec F, et al. Lancet. 1989 Dec 2;2(8675):1335-6. doi: 10.1016/s0140-6736(89)91940-5. Lancet. 1989. PMID: 2574281 No abstract available.